
Opinion|Videos|July 15, 2024
The Role of Treatment Guidelines for HS
Author(s)Vivian Shi, MD, FAAD
Vivian Shi, MD, FAAD, provides an overview of current treatment guidelines for hidradenitis suppurativa and discusses ways to improve upon them.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What do current hidradenitis suppurativa (HS) treatment guidelines recommend in terms of using biologics in moderate-to-severe disease?
Advertisement
Related to this article

In a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated questionnaire.

San Francisco experts say payer step edits and weak biologic follow-up slow atopic dermatitis care and point to pharmacy teams and dashboards.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First siRNA Therapy for AChR-Positive Myasthenia Gravis
2
Most Patients With Psoriasis Screened Positive for PsA at One Dermatology Clinic
3
Iron Deficiency in Heart Failure Is a Workflow Problem, Faculty Say
4
Low CRC Incidence Found After Endoscopic Mucosal Resection
5


